InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong · Delayed Price · Currency is HKD 42.06
-1.44 (-3.31%)
Jul 30, 2026, 4:08 PM HKT
HKG:3696 Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, HKG:3696 stock has a consensus rating of "Strong Buy" and an average price target of $80.66. The average 1-year stock price forecast is 91.77% higher than the current stock price, while the lowest is $71.02 (+68.85%) and the highest is $100.00 (+137.76%).
Price Target: $80.66 (+91.77%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:3696 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 3 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 4 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $71.00 | Buy | Maintains | $71.00 | +68.81% | Jul 23, 2026 |
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $84.50 | Buy | Maintains | $84.50 | +100.90% | Jul 22, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $77.00 | Buy | Maintains | $77.00 | +83.07% | Jul 15, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $76.80 | Buy | Maintains | $76.80 | +82.60% | Apr 8, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $77.97 | Buy | Maintains | $77.97 | +85.38% | Mar 27, 2026 |
Financial Forecast
Revenue This Year
178.61M
from 56.24M
Increased by 217.59%
Revenue Next Year
252.51M
from 178.61M
Increased by 41.37%
EPS This Year
0.03
from -0.56
EPS Next Year
0.08
from 0.03
Increased by 194.04%
EPS and Forward PE are based on non-GAAP adjusted numbers.